# Dinoprostone

## Prostin E2 Vaginal Tablet 3mg

| TAH Drug Code      | [EPROS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EPROS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Induction & augmentation of labor near term.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Initially， insert 1 vaginal tablet high into posterior fornix. Second tablet may be inserted after 6-8 hr if labor is not established. the maximum dose: 6 mg in 24 hr.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Prostaglandin should not be used in patients who are allergic to any components of the drug (including the active ingredient Dinoprostone or other excipients). Prostaglandin and other labor-inducing agents should be avoided in the following conditions: - Multiple pregnancies. - History of multiple full-term pregnancies (six or more). - When the fetal head has not engaged in the birth canal. - Previous uterine surgeries (e.g.， cesarean section， uterine incision). - Fetal head disproportionate to the mother's pelvis. - Fetal distress indicated by abnormal fetal heart rate. - When risk assessment for both the mother and fetus suggests that surgical intervention is more appropriate. - Unexplained vaginal discharge and/or abnormal uterine bleeding during pregnancy. - Non-cephalic presentation of the fetus. |
| Adverse Effects    | Common: Diarrhea (Vaginal insert， <1%; vaginal suppository， approximately 40%)， Nausea (Vaginal insert， <1%; vaginal suppository， 33%)， Vomiting (Vaginal insert， <1%; vaginal suppository， approximately 66%)， Headache (Vaginal suppository， approximately 10%)， Fever (vaginal insert， <1%)， Shivering (Vaginal suppository， approximately 10%) Serious: Decreased diastolic arterial pressure (Vaginal suppository， 10%)， Myocardial infarction， Disseminated intravascular coagulation， Hypersensitivity reaction， Hypertonic uterine dysfunction (Vaginal insert， 2-4.7%)， Infection of amniotic cavity， Intrauterine sepsis of fetus， Non-allergic anaphylaxis， Premature rupture of membranes， Rupture of uterus， Vaginospasmm， Fetal distress (Vaginal insert， 2.9-3.8%)                                  |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dinoprostone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

